Matches in Wikidata for { <http://www.wikidata.org/entity/Q64643845> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q64643845 description "clinical trial" @default.
- Q64643845 description "ensayu clínicu" @default.
- Q64643845 description "klinisch onderzoek" @default.
- Q64643845 description "клінічне випробування" @default.
- Q64643845 name "Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia" @default.
- Q64643845 type Item @default.
- Q64643845 label "Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia" @default.
- Q64643845 prefLabel "Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia" @default.
- Q64643845 P1050 Q64643845-8CF269C8-096B-416F-8465-48FF99065B4A @default.
- Q64643845 P1132 Q64643845-E9899584-2892-4946-B1CC-F8596804E6F1 @default.
- Q64643845 P1476 Q64643845-86ACB4B2-7FBF-40B3-8ABC-6F149C61BC57 @default.
- Q64643845 P17 Q64643845-43AA976D-FF74-487A-860E-68E7475BA0BE @default.
- Q64643845 P2899 Q64643845-E7741BB4-36A1-4796-BF03-67DA69A56A6B @default.
- Q64643845 P3098 Q64643845-507F2C60-993C-426C-BC25-65E94F278D7D @default.
- Q64643845 P31 Q64643845-F77DCF2F-CC4B-45A9-9B96-8C3B18A9894B @default.
- Q64643845 P4135 Q64643845-7E3AC6B8-F33E-4A75-8385-4264FA9F1ADC @default.
- Q64643845 P4844 Q64643845-0F1E8CD5-6CCA-4D3C-82C2-539B99BE295F @default.
- Q64643845 P580 Q64643845-5E0C29CC-2B16-4018-9DF2-BFE30E57465A @default.
- Q64643845 P582 Q64643845-8B1BB7AD-9C90-4583-8868-36CD5D7A568B @default.
- Q64643845 P6099 Q64643845-8C96A9CD-ADB8-4BB5-B159-AECADDEB1D0E @default.
- Q64643845 P6153 Q64643845-F5D3547C-7D19-46C8-A0EC-B92C8173C913 @default.
- Q64643845 P8363 Q64643845-C73E5226-5D79-4CA5-888E-F4A490D55E23 @default.
- Q64643845 P859 Q64643845-D5F24E8C-DC25-4A16-9496-DE5C91BA9319 @default.
- Q64643845 P1050 Q83030 @default.
- Q64643845 P1132 "+121" @default.
- Q64643845 P1476 "A 52-week, Prospective, Multi-center, Open-label Study to Assess the Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Patients With Alzheimer's Dementia in a Controlled Titration Schedule" @default.
- Q64643845 P17 Q865 @default.
- Q64643845 P2899 "+50" @default.
- Q64643845 P3098 "NCT01585272" @default.
- Q64643845 P31 Q30612 @default.
- Q64643845 P4135 "+85" @default.
- Q64643845 P4844 Q411887 @default.
- Q64643845 P580 "2012-08-01T00:00:00Z" @default.
- Q64643845 P582 "2015-06-01T00:00:00Z" @default.
- Q64643845 P6099 Q42825046 @default.
- Q64643845 P6153 Q507154 @default.
- Q64643845 P8363 Q78089383 @default.
- Q64643845 P859 Q507154 @default.